A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations
Sarah Brown(University of Leeds), Richard Adams(Velindre Cancer Centre), Chris Hurt(Cardiff University), Emma Hall(Institute of Cancer Research), Andrew Scarsbrook(University of Leeds), Martin Förster, Richard D. Baird(Cancer Research UK), Samantha Hinsley(University of Leeds)
Cited by 8
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k